Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - OTHER CURRENT ASSETS
Other Current Assets ESPR - Esperion Therapeutics, Inc.
4.7 M
LAST VALUE
-38.21%
2 YEAR CAGR
-6.59%
5 YEAR CAGR
17.72%
10 YEAR CAGR